A critical comparison of three internalization assays applied to the evaluation of a given mAb as a toxin-carrier candidate

[1]  S. Ménard,et al.  p185 HER2/neu epitope mapping with murine monoclonal antibodies. , 1992, Hybridoma.

[2]  S. Ménard,et al.  Glycolipids carrying Ley are preferentially expressed on small‐cell lung cancer cells as detected by the monoclonal antibody MLuC1 , 1992, International journal of cancer.

[3]  R. G. Anderson,et al.  Potocytosis: sequestration and transport of small molecules by caveolae. , 1992, Science.

[4]  V. Zurawski,et al.  Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. , 1991, Cancer research.

[5]  Wawrzynczak Ej.  Systemic immunotoxin therapy of cancer: advances and prospects. , 1991 .

[6]  E. Wawrzynczak,et al.  Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicity. , 1991, The British journal of cancer. Supplement.

[7]  S. Canevari,et al.  Use of combination of monoclonal antibodies directed against three distinct epitopes of a tumor‐associated antigen: Analysis of cell binding and internalization , 1991, International journal of cancer.

[8]  S. Canevari,et al.  Preparation and biological characterization of conjugates consisting of ricin and a tumor-specific non-internalizing MAb. , 1991, Anticancer research.

[9]  R. Chignola,et al.  Distribution of endocytosed molecules to intracellular acidic environments correlates with immunotoxin activity , 1990, International journal of cancer.

[10]  S. Canevari,et al.  Fractionation of the ribosome inactivating protein preparations with triazine dyes. , 1990, Biochemical and biophysical research communications.

[11]  A. Harris.  The epidermal growth factor receptor as a target for therapy. , 1990, Cancer cells.

[12]  A. Ullrich,et al.  Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. , 1990, Cancer research.

[13]  T. Yamaguchi,et al.  Antigenic modulation and internalization of monoclonal antibody to human colonic carcinoma cells detected by enzyme‐linked immunosorbent assay , 1989, International journal of cancer.

[14]  I. Gigli,et al.  Endocytosis and shedding of the decay accelerating factor on human polymorphonuclear cells. , 1989, Journal of immunology.

[15]  S. Watkins,et al.  Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis , 1989, Journal of cellular physiology.

[16]  R. Reisfeld,et al.  Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Foon.  Biological response modifiers: the new immunotherapy. , 1989, Cancer research.

[18]  S. Canevari,et al.  The Aspergillus toxin restrictocin is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cells , 1989 .

[19]  O. Petersen,et al.  Immunotoxins--entry into cells and mechanisms of action. , 1989, Immunology today.

[20]  E. Yunis,et al.  Receptor-like nature of class I HLA: endocytosis via coated pits. , 1988, Journal of immunology.

[21]  J. Calafat,et al.  Endocytosis and intracellular routing of an antibody-ricin A chain conjugate. , 1988, Cancer research.

[22]  O. Fodstad,et al.  New indirect approach to the therapeutic use of immunotoxins. , 1988, Journal of the National Cancer Institute.

[23]  R. Youle.  Fatal attraction in vitro and in vivo. , 1988, Journal of the National Cancer Institute.

[24]  J. Uhr,et al.  An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins. , 1988, Cancer research.

[25]  J. Weltman,et al.  Rapid screening with indirect immunotoxin for monoclonal antibodies against human small cell lung cancer. , 1987, Cancer research.

[26]  M. Herlyn,et al.  Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas. , 1987, Cancer research.

[27]  S. Canevari,et al.  Internalization of a monoclonal antibody against human breast cancer by immunoelectron microscopy. , 1987, British Journal of Cancer.

[28]  S. Ménard,et al.  Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificity , 1987, International journal of cancer.

[29]  S. Warnaar.  Selection of Monoclonal Antibodies. , 1987 .

[30]  I. Pastan,et al.  Immunotoxins , 1986, Cell.

[31]  Baldwin Rw,et al.  Endocytosis of a monoclonal antibody recognising a cell surface glycoprotein antigen visualised using fluorescent conjugates. , 1986 .

[32]  E. Bröcker,et al.  Modes of binding and internalization of monoclonal antibodies to human melanoma cell lines. , 1986, Cancer research.

[33]  R. W. Baldwin,et al.  Endocytosis of a monoclonal antibody recognising a cell surface glycoprotein antigen visualised using fluorescent conjugates. , 1986, European journal of cell biology.

[34]  S. Ménard,et al.  Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. , 1983, Cancer research.

[35]  C. Jenkin,et al.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. , 1978, Immunochemistry.

[36]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[37]  J. Marchalonis.  An enzymic method for the trace iodination of immunoglobulins and other proteins. , 1969, The Biochemical journal.